Long-awaited findings from an international study of more than 17,000 patients showed the weight loss drug Wegovy reduced the risk of having a heart attack or stroke, and the risk of dying from a heart attack.

As applications for pharmacy schools and residency programs wither, hospital pharmacy leaders are warily preparing for a shortage of clinical pharmacists. 

Despite financial headwinds, the healthcare industry is plugging money and resources into home infusion service lines, according to Provident Healthcare Partners.

The FDA on Nov. 9 granted approval to Ixchiq, the first vaccine to protect against chikungunya virus. 

The chief medical officer of Walgreens Boots Alliance, Kevin Ban, MD, will exit his role as of Nov. 10, a spokesperson confirmed to Becker's.

Walgreens is planning to lay off about 5% of its corporate workforce, or 267 employees, the Chicago Tribune reported Nov. 9.

Hospital and health system pharmacy leaders might be missing out on big-picture goals in "emerging frontiers" as they extinguish long-standing issues, such as rising healthcare costs and a pharmacy technician shortage, according to an Oct. 7 article from McKinsey. 

Shelling out nearly $16,000 for a 14-day course of medication is what to expect for the wholesale cost of Zurzuvae, the first oral treatment for postpartum depression, according to a Nov. 7 news release from drugmaker Sage Therapeutics. 

After a three-day walkout of retail pharmacy employees across the U.S., organizers of the grassroots labor action created an organization that seeks to unionize the workforce and advocate for safer working conditions. 

As 2023 entered its fourth quarter, one cancer drug shortage resolved as more than a dozen continue; a California system helped make a chemotherapy management app; and the FDA approved a new head and neck cancer medication. 

On Nov. 8, the FDA approved Eli Lilly's Zepbound (tirzepatide), a weekly injection for chronic weight management. 

Accord Healthcare, a London-based drugmaker, resumed manufacturing of two methotrexate solutions, according to a Nov. 7 update from the FDA. 

The FDA is investigating reports of hospitalizations tied to suspected counterfeit versions of semaglutide drugs, including three in the U.S., according to records from the agency's adverse event reporting system. 

As hundreds of pharmacy and imaging workers for Kaiser Permanente strike, a spokesperson for the system told CBS affiliate KPIC their union's ask for a 43% raise over the next four years is "frankly, not reasonable."

Pneumonia patients who took an antibiotic that's typically reserved as an alternative were less likely to develop Clostridioides difficile infections compared to those taking the recommended drug, according to a study from Veterans Affairs Hospitals. 

The U.S. healthcare industry could save more than $1.1 trillion and prevent about 15 million heart attacks over the next 30 years if pharmacists were more involved in hypertension care, according to research conducted by Virginia Commonwealth University in Richmond. 

Organizations representing thousands of hospital pharmacies are criticizing CMS' plan to not provide further reimbursement to 340B hospitals after paying a $9 billion lump sum. 

Nurix Therapeutics, a drugmaker based in San Francisco, said the FDA has placed a partial clinical hold on its phase 1 trial for an experimental drug for lymphoma and leukemia. 

Sixteen years after pharmacists from the University of Florida College of Pharmacy in Gainesville petitioned the FDA to require new efficacy studies of an ingredient in decongestants, their efforts came to fruition. In September, an FDA panel unanimously declared the ingredient ineffective. 

Salt Lake City-based Intermountain Health is one of the latest health systems to enter the emerging world of prescription delivery via drone.